Apolipoprotein E in Creutzfeldt-Jakob disease

Yasushi Nakagawa; Tetsuyuki Kitamoto; Hisako Furukawa; Koji Ogomori; Jun Tateishi; Inga Zerr; Marion Helmhold; Thomas Weber; Allen D. Roses; Ann Marie Saunders; Warren J. Strittmatter; Donald E. Schmechel; Margaret A. Pericak-Vance; Bradley Hyman

doi:10.1016/S0140-6736(95)91196-0

Apolipoprotein E in Creutzfeldt-Jakob disease

Yasushi Nakagawa, Tetsuyuki Kitamoto, Hisako Furukawa, Koji Ogomori, Jun Tateishi, Inga Zerr, Marion Helmhold, Thomas Weber, Allen D. Roses, Ann Marie Saunders, Warren J. Strittmatter, Donald E. Schmechel, Margaret A. Pericak-Vance, Bradley Hyman

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	68-69
Number of pages	2
Journal	The Lancet
Volume	345
Issue number	8941
DOIs	https://doi.org/10.1016/S0140-6736(95)91196-0
Publication status	Published - 1995 Jan 7
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(95)91196-0

Cite this

@article{ae1143d040eb4f649b1a8b53b8e06e76,

title = "Apolipoprotein E in Creutzfeldt-Jakob disease",

author = "Yasushi Nakagawa and Tetsuyuki Kitamoto and Hisako Furukawa and Koji Ogomori and Jun Tateishi and Inga Zerr and Marion Helmhold and Thomas Weber and Roses, {Allen D.} and Saunders, {Ann Marie} and Strittmatter, {Warren J.} and Schmechel, {Donald E.} and Pericak-Vance, {Margaret A.} and Bradley Hyman",

note = "Funding Information: results could be attributable to selection bias since Amouyel{\textquoteright}s control groups 1, 2, and 4 had a mean age 15 years older than their CJD group and control group 3 (10 years lower). To clarify this issue age-matched and sex-matched controls from the continuing European CJD surveillance study should be examined to exclude any possible selection bias. This study was supported by a grant from the Bundesministerium fur Gesundheit to TW (324-4473-05/3).",

year = "1995",

month = jan,

day = "7",

doi = "10.1016/S0140-6736(95)91196-0",

language = "English",

volume = "345",

pages = "68--69",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8941",

}

TY - JOUR

T1 - Apolipoprotein E in Creutzfeldt-Jakob disease

AU - Nakagawa, Yasushi

AU - Kitamoto, Tetsuyuki

AU - Furukawa, Hisako

AU - Ogomori, Koji

AU - Tateishi, Jun

AU - Zerr, Inga

AU - Helmhold, Marion

AU - Weber, Thomas

AU - Roses, Allen D.

AU - Saunders, Ann Marie

AU - Strittmatter, Warren J.

AU - Schmechel, Donald E.

AU - Pericak-Vance, Margaret A.

AU - Hyman, Bradley

N1 - Funding Information: results could be attributable to selection bias since Amouyel’s control groups 1, 2, and 4 had a mean age 15 years older than their CJD group and control group 3 (10 years lower). To clarify this issue age-matched and sex-matched controls from the continuing European CJD surveillance study should be examined to exclude any possible selection bias. This study was supported by a grant from the Bundesministerium fur Gesundheit to TW (324-4473-05/3).

PY - 1995/1/7

Y1 - 1995/1/7

UR - http://www.scopus.com/inward/record.url?scp=0028817272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028817272&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(95)91196-0

DO - 10.1016/S0140-6736(95)91196-0

M3 - Letter

C2 - 7799732

AN - SCOPUS:0028817272

SN - 0140-6736

VL - 345

SP - 68

EP - 69

JO - The Lancet

JF - The Lancet

IS - 8941

ER -

Apolipoprotein E in Creutzfeldt-Jakob disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this